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The development of the nervous system is a time-ordered
and multi-stepped process that requires neural speciﬁca-
tion, axonal navigation and arbor reﬁnement at the target
tissues. Previous studies have demonstrated that the trans-
cription factor Zic2 is necessary and sufﬁcient for the
speciﬁcation of retinal ganglion cells (RGCs) that project
ipsilaterally at the optic chiasm midline. Here, we report
that, in addition, Zic2 controls the reﬁnement of eye-
speciﬁc inputs in the visual targets by regulating directly
the expression of the serotonin transporter (Sert), which is
involved in the modulation of activity-dependent mechani-
sms during the wiring of sensory circuits. In agreement
with these ﬁndings, RGCs that express Zic2 ectopically
show defects in axonal reﬁnement at the visual targets and
respond to pharmacological blockage of Sert, whereas
Zic2-negative contralateral RGCs do not. These results
link, at the molecular level, early events in neural differ-
entiation with late activity-dependent processes and
propose a mechanism for the establishment of eye-speciﬁc
domains at the visual targets.
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Introduction
Sense organs are responsible for the perception of the
surrounding environment. During the development of the
nervous system, sensory organs have to connect to
the appropriate target areas in the brain in order to function
normally. The visual system has long been an ideal model
system for understanding how development sculpts the orga-
nization of sensory circuits. In the visual system of mammals,
retinal ganglion cells (RGCs) from each eye diverge at the
optic chiasm midline to send axonal projections to the main
visual targets—the thalamic lateral geniculate nucleus (LGN)
and the superior colliculus (SC)—at both sides of the brain.
In the mouse, most visual ﬁbres cross the midline (contral-
ateral) except for a few axons that arise from the peripheral
ventrotemporal (VT) region of the retina that avoid the mid-
line and project instead to the same side of the brain
(ipsilateral) (Erskine and Herrera, 2007).
To maintain positional information of the visual ﬁelds
and allow binocular vision, the ﬁnal projection pattern of
visual ﬁbres at the targets follows two remarkable features:
(1) topography along the anteroposterior and the latero-
medial axis and (2) eye-speciﬁc segregation of ipsilateral
and contralateral axons (Godement et al, 1984; Chapman
and Stryker, 1993; Chapman et al, 1996; McLaughlin et al,
2003; Huberman et al, 2008). At birth, when RGC axons reach
the visual targets, they initially invade the entire SC and
LGN (Sretavan et al, 1988; McLaughlin et al, 2003) but after a
precise reﬁnement process, the topographic and eye-speciﬁc
projection pattern are well deﬁned around 2 weeks after
birth.
The molecular program that controls early guidance events
of retinal axons at the optic chiasm has been described
clearly. The transcription factor Zic2 is expressed in un-
crossed (iRGCs) but not in crossed (cRGCs) ganglion cells,
and is necessary and sufﬁcient to control the expression of
the guidance receptor EphB1 (Herrera et al, 2003; Garcia-
Frigola et al, 2008). Glial cells at the optic chiasm express
EphrinB2, an EphB1 ligand, and the interaction of these two
membrane proteins mediates the axonal repulsive response
of ipsilateral axons at the midline (Williams et al, 2003).
The molecular mechanisms governing the subsequent
steps that visual ﬁbres follow to establish the ﬁnal projection
pattern at their targets are starting to be elucidated.
The establishment of topographic maps in both ipsilateral
and contralateral ﬁbres is mediated by the tyrosine kinase
receptors EphAs and their ligands, the ephrinAs. Mice lacking
EphA/ephrinA signalling show defects in axonal mapping at
the SC and the thalamus. Mutations in the transmembrane
protein, Ten_m3, or in the multi-domain protein Phr1 also
lead to defects in the mapping of RGC axons. However,
none of these molecules are differentially expressed in iRGC
or cRGCs and consequently the segregation of ipsilateral and
contralateral ﬁbres in all these mutant mice is not affected
(Pfeiffenberger et al, 2005; Leamey et al, 2007; Culican et al,
2009).
In contrast, the reﬁnement of retinal axons is perturbed
when neural activity is manipulated. Thus, in mice that lack
b2 subunits of the neuronal nicotinic acetylcholine receptor,
or in ferrets that receive intraocular injections of epibatidine,
stage II spontaneous waves are abolished and although axons
project to the correct retinotopic location in the targets, they
form diffuse axonal arborizations and ipsilateral and contra-
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3170lateral processes do not segregate properly (Penn et al, 1998;
Rossi et al, 2001). In addition, when serotonin signalling, a
well-characterized pathway involved in the modulation of
neural activity (Gu and Singer, 1995; Mazer et al, 1997;
Sarnyai et al, 2000; Edagawa et al, 2001; Gaspar et al, 2003;
Sodhi and Sanders-Bush, 2004), is genetically or pharmaco-
logically altered axon reﬁnement and proper axonal arbori-
zation are disrupted in the visual and in other sensory
systems (Rhoades et al, 1993; Arce et al, 1995; Bastos et al,
1999; Upton et al, 1999, 2002; Salichon et al, 2001; Butt et al,
2002; Xu et al, 2004; Gonzalez et al, 2008).
Despite the fact that the formation of the visual system in
mammals has served as a model for studying axonal naviga-
tion at the midline and the coupling of neural sensory inputs
in the targets, the molecular connection between both pro-
cesses has been poorly investigated. Here, we report that the
transcription factor Zic2 regulates directly the expression of
the serotonin transporter (Sert) in iRGCs to reﬁne eye-speciﬁc
projections in primary visual targets. These results reveal that
the same transcription factor that controls axon guidance
in an intermediate target also regulates activity-dependent
reﬁnement events at the ﬁnal targets.
Results
Zic2 and Sert are co-expressed in ipsilateral RGCs
To search for Zic2 target genes, we compared the gene
expression proﬁles of VT retinal segments of embryonic day
E16.5. WT and Zic2 mutant embryos (Zic2
kd/kd) (Nagai et al,
2000). Only seven probe sets fulﬁlled the restrictive criteria
applied to identify bona ﬁde targets of Zic2 (Figure 1; for
further details in microarrays results see Supplementary Figure
S1). The only two downregulated genes in the list were the
neural precursor cell-expressed, developmentally downregu-
lated gene 9 (Nedd9/HEF1) and the serotonin transporter (Sert;
encoded by slc6a4). Nedd9/HEF1 is a scaffolding protein in the
integrin signalling pathway involved in cell adhesion dy-
namics (O’Neill et al, 2000) and may represent an interesting
candidate target gene for further study. Here, we focus on Sert,
an integral membrane protein responsible for the efﬁcient
uptake of serotonin from the extracellular space. This was
the most downregulated gene in our analysis ( 3.4-fold).
To evaluate the relationship between Zic2 and Sert, we
performed double staining, combining immunohistochemis-
try against Zic2 and in situ hybridization for Sert transcripts,
on retinal cryosections from E16.5 mouse embryos. We found
that both genes were co-expressed by the same cells in
the most peripheral VT segment of the retina (Figure 2A),
the location of iRGCs. To investigate whether Sert, like Zic2,
is expressed in iRGCs and not in cRGCs, we performed
immunostaining for Sert in semi-intact whole-mount prepara-
tions of the ventral diencephalon containing the entire optic
chiasm region. Sert staining was clearly detectable in retinal
axons turning ipsilaterally at the optic chiasm, whereas Sert-
positive retinal axons crossing the midline were not observed
(Figure 2B). This suggests that Sert is expressed speciﬁcally
in iRGCs and not in both iRGCs and cRGCs as thought
previously (Upton et al, 1999).
Next, we compared the temporal expression patterns of
Zic2 and Sert at different developmental stages. As described
previously, Zic2 expression ﬁrst appeared in the peripheral
VT segment at E14.5 (Herrera et al, 2003). Consistent with
Zic2 expression, Sert mRNA was detected in the VT retina at
this age. At E16.5, when the expression of Zic2 peaked in the
VTretina, Sert mRNA also was expressed highly in a domain
identical to that of Zic2. At P0, the expression of both
genes was found at the very periphery of the VT retina, and
by P4 and later stages both molecules were undetectable
(Figure 2C). The co-incidental spatiotemporal expression of
Zic2 and Sert in the mouse retina, together with the expres-
sion of Sert in ipsilateral but not in contralateral RGC axons,
make this gene an excellent candidate as a Zic2 downstream
effector molecule.
Zic2 is necessary and sufﬁcient to induce the
expression of Sert
To further test whether Zic2 is required for Sert expression in
the VTregion of the retina, we examined Sert mRNA levels in
Zic2 hypomorphic mutant mice (Zic2
kd/kd). These mice die
around E17.5 and display barely detectable levels of Zic2
(Herrera et al, 2003). We therefore examined Sert mRNA
expression at E16.5 in Zic2
kd/kd and wild-type littermates
when both Zic2 and Sert expression levels peak in the retina
(Figure 2C). Sert mRNA levels were highly reduced in the VT
retina of Zic2
kd/kd embryos compared with WT littermates
(Figure 3A). These data indicate that Zic2 expression in the
developing neural retina is necessary for the expression of
Sert in iRGCs.
Next, we assessed whether Zic2 is sufﬁcient to induce Sert
expression in vivo. Speciﬁc primers were designed to detect
Sert mRNA in mouse embryonic retinas by quantitative
RT–PCR (qRT–PCR). To validate the primers, dorsonasal
(DN) and VT retinal segments were dissected out from
E16.5 WT embryos and endogenous levels of Sert mRNA
were measured. VT segments showed an increase of around
3.5-fold in Sert mRNA levels compared with segments from
the DN region of the retina (Figure 3B). Using the highly
efﬁcient in utero electroporation protocol developed in our
laboratory (Garcia-Frigola et al, 2007, 2008), mammalian
expression vectors containing EGFP (pCAG-EGFP) or/and
Zic2 (pCAG-Zic2)-coding sequences were ectopically intro-
duced into RGCs of the centre of the retina at E13.5 At 1 or 3
days after electroporation, the targeted central portions of the
retina were dissected out and Sert mRNA levels measured by
Figure 1 Gene expression analysis comparing VT retinal segments
from E16.5 WT and Zic2 mutant retinas. Hit map generated from
the DNA microarray data showing the seven probe sets/transcripts
(six genes) signiﬁcantly altered on samples from Zic2 knockdown
mice (Zic2
kd/kd) with fold change larger than 2 (Po0.05, unpaired
t-test). This graph was generated using the GeneSpring GX software.
The probe-set ID (left), gene symbol, average fold change over
triplicate microarrays (FC) and P-values for each transcript are
indicated. The colour scale bar indicates upregulation in red and
downregulation in blue.
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and pCAG-EGFP (Zic2/EGFP) and collected 24 or 72h after
electroporation showed a signiﬁcant increase of 2.0-fold
and 2.5-fold, respectively, in the levels of Sert mRNA com-
pared with samples electroporated with pCAG-EGFP alone
(Figure 3B). Together, these results indicate that, in vivo, Zic2
is necessary and sufﬁcient to induce Sert expression in the
mouse retina.
Zic2 directly activates Sert transcription
To determine if Sert is a direct transcriptional target of Zic2,
we investigated whether this transcription factor acti-
vates Sert regulatory sequences. In order to ﬁnd common
mechanisms for the regulation of Sert expression conserved
through evolution, we used the Vista browser to align se-
quences upstream of the 50UTR of the Sert gene from six
different mammalian species (human, monkey, dog, horse,
rat and mouse) (Figure 4A). We found a 130-bp fragment
immediately upstream of the transcriptional start site (TSS)
(Bengel et al, 1997) that was highly conserved. Interestingly,
this fragment contained fundamental information to drive
transcription, including a TATA-like motif, a cyclic-AMP res-
ponse element motif, a CG-rich sequence and several potential
binding sites for transcription factors including Gli (Figure 4A).
To study the potential capacity of Zic2 to activate Sert
transcription, the 130-bp conserved sequence (putative Sert
Figure 2 Spatio-temporal co-localization of Zic2 and Sert in iRGCs. (A) Fluorescent immunostaining against Zic2 (green) combined with
in situ hybridization for Sert (red) performed in a coronal section from an E16.5 mouse retina shows that Zic2 and Sert are expressed in the
peripheral ventrotemporal retina. Below each image, higher magniﬁcations of the corresponding-squared areas are shown. (B, a) Colorimetric
immunostaining against Zic2 combined with in situ hybridization for Sert demonstrate that cells expressing Sert mRNA (purple) are Zic2-
positive neurons (brown). Black arrowheads highlight cells that are double positive for Zic2 and Sert mRNA. The right corner contains, a high
magniﬁcation of the squared area. np, neural progenitors; cb, ciliary body. Scale bar: 100mm. (B, b) Scheme showing a ventral view of the
diencephalon that includes the optic chiasm area. Black lines represent contralateral axons and red lines represent ipsilateral axons. (B,c )
The picture shows an immunohistochemistry against Sert (red) performed in a semi-intact preparation that contains the optic chiasm region.
Sert expression is localized in ipsilateral axons, whereas axons crossing the midline are Sert negative. on, optic nerve; ot, optic tract. Scale bar:
100 mm. (C) Top panels show immunostaining against Zic2 (white arrows) in VT retinal sections from E12.5 (d, e) E14.5 (f, g), E16.5 (h, i),
P0 (j, k), P4 (l, m) and P9 (n, o) mice. Bottom panels show in situ hybridization against Sert mRNA (black arrows) in the same sections.
The expression of both genes peaks at E16.5 and it is completely downregulated by P4. RGCs, retinal ganglion cells; cb, ciliary body; np, neural
progenitors. Scale bar: 100mm.
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luciferase reporter plasmid (pGL3-basic), and used for luci-
ferase assays in 293HEK cells. The transfection of the empty
pGL3-basic plasmid, plus the empty pCAG plasmid or a
mammalian expression vector containing the full-length
Zic2 sequence (pCAG-Zic2), all resulted in basal luciferase
activity. When pGL3 bearing the putative sert promoter
region (pGL3-Sert promoter) was co-transfected with an
empty pCAG plasmid, luciferase activity above the basal
level was detected, conﬁrming the previously reported
transcriptional activity of this region (Heils et al, 1998).
When pCAG-Zic2 was transfected in combination with the
pGL3-Sert promoter into 293HEK cells, the luciferase levels
increased more than seven-fold compared with the levels
from the pGL3-Sert promoter and the empty pCAG
plasmid. This demonstrates that Zic2 is able to bind to this
130bp-basic sert promoter region and activate transcription
(Figure 4B). We also tested the activity of the TATA-like domain
together with the GC-rich domain. However, this sequence
alone was not able to augment basal luciferase activity in
either the presence or absence of Zic2. Thus, the rest of the
elements in the 130-bp fragment located upstream of the sert
TSS are essential to induce transcription (data not shown).
Although the molecular mechanism of Zic gene-regulatory
function is poorly understood, with few available in vivo
validated DNA-binding sequences, Zic genes are known
to bind to Gli sites (Mizugishi et al, 2001). Thus, in order
to further characterize the domain where Zic2 is binding
inside the conserved 130bp sert promoter, we mutated
the Gli-binding site (Gli-BS). This resulted in a signiﬁcant
reduction in the activation of the sert promoter (Figure 4B).
However, the basal activity of the promoter also
Figure 3 Zic2 is necessary and sufﬁcient for the expression of Sert in the retina. (A) The images show coronal retinal sections from WT (a–c),
and homozygous Zic2
kd/kd (d–f) E16.5 littermate embryos. Immunostaining against Zic2 in these sections shows that it is expressed in the VT
retina in Zic2
þ/þ and disappears in Zic2
kd/kd embryos. In situ hybridization to Sert (red) in the same retinal sections demonstrates that Sert is
highly downregulated in the absence of Zic2. Scale bars: 100mm. (B) The top panel shows quantitative RT–PCR analysis performed on
segments from dorsonasal (DN) or VT E16.5 WTretinas to detect Sert mRNA. Sert mRNA levels were three-fold higher in the VT than in the DN
retina. The bottom panel shows quantitative RT–PCR comparisons for Sert mRNA performed on central retinas of embryos electroporated at
E13.5 with CAG-EGFP or with CAG-Zic2/CAG-EGFP plasmids and dissected out 24 or 72h after electroporation. At least three retinas for each
condition were pooled per experiment. The average of three and ﬁve different experiments is shown for 24 and 72h, respectively. Error bars
indicate ±s.e.m. (*Po0.05, Student’s unpaired t-test).
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could account for the decreased activation by Zic2 we created
two independent mutations in the sert promoter that also
produced signiﬁcant reductions in basal activity. However,
neither of these mutations changed the ability of Zic2 to
activate the sert promoter (Figure 4B). This suggests that Zic2
interacts speciﬁcally with the Gli-BS.
Given that in 293HEK cells Zic2 increases the luciferase
activity driven by the conserved region of the sert promoter,
we determined whether Zic2 binds to this Sert regulatory
sequence in the retina in vivo. Chromatin immunoprecipita-
tion (ChIP) assays were carried out using anti-Zic2-speciﬁc
antibodies and chromatin from VT retinal segments of E16.5
WT mouse embryos. Primers ﬂanking the 130-bp sert pro-
moter region were used for PCR ampliﬁcation. The ChIP
assays conﬁrmed the speciﬁc binding of Zic2 to the 130-bp
sequence located immediately upstream of the sert TSS. No
PCR product was detected in the negative control using
primers designed to an adjacent region upstream of the
conserved promoter region (1Kb upstream of the sert TSS).
As a positive control, an anti-Acetyl-Histone3 (AcH3) anti-
body was used (Figure 4C). These results demonstrate that
Zic2 is able to regulate the expression of Sert in iRGCs in vivo
by direct binding to its promoter region.
RGCs that ectopically express Zic2 project in the
contralateral domain of visual targets
The function of the serotonin signalling pathway, and more
speciﬁcally Sert, in visual system development had been
characterized previously. Mice that lack Sert or that have
Figure 4 Zic2 directly regulates Sert expression. (A) VISTA view of the occurrence of conserved sequence domains upstream of the ﬁrst sert
exon (purple arrow). Light blue arrow indicates the consensus transcription start site of sert (TSS). Shown from top to bottom are human
versus mouse (H/M), monkey versus mouse (M/M), dog versus mouse (D/M), horse versus mouse (H/M) and rat versus mouse (R/M)
sequences. The coloured peaks (purple: coding, blue: UTR, pink: conserved non-coding regions) indicate regions of at least 100bp, with a
conservation score of at least 75%. The pink arrow indicates a highly conserved peak of 130bp upstream of the TSS that has been proposed as
the basal Sert promoter sequence. The 130bp mouse sequence of the conserved Sert promoter, including putative binding sites (in different
colours) for the indicated transcription factors is graphically represented below the VISTA comparison. (B) Luciferase assays to evaluate the
transcriptional activity of Zic2 on the 130bp Sert promoter region. After transfection of pCAG-Zic2 in 293HEK cells together with luciferase
vectors containing the 130-bp Sert promoter region, Zic2 increases the basal transcriptional activity of the 130-bp conserved Sert promoter
more than seven-fold compared with the controls. A mutation in the Gli-binding sequence signiﬁcantly reduces this induction. By contrast,
mutations in the CRE-like motif or the GC-rich domain of the sert promoter had no effects on the induction by Zic2. The values represent
means±s.e.m. of at least four triplicates, except for pGL3-GC with two triplicates (*Po0.01, Student’s unpaired t-test). (C) ChIP assays
demonstrate that Zic2 binds to the basal promoter region of Sert in the embryonic E16.5 VT retina in vivo. In the upper panel, primers to
amplify the 130-bp Sert basal promoter were used, whereas in the bottom panel, control primers to amplify a 50upstream non-conserved
sequence were used. Zic2 binds to the Sert basal promoter (black arrow) but not to the control sequence (black arrowhead). Anti-AcH3
antibodies were used as positive controls and non-speciﬁc rabbit serum as negative control (IgGs).
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speciﬁc reﬁnement process of ipsilateral RGC axons (Upton
et al, 1999; Salichon et al, 2001), an alteration that we have
also conﬁrmed (Supplementary Figure S2). On the basis of
these ﬁndings and given that Zic2 controls Sert expression in
iRGCs, we decided to examine whether Zic2 has a function in
reﬁnement at the visual targets.
Zic2
kd/kd mice die at embryonic stages and a conditional
approach to remove Zic2 speciﬁcally in the eye and analyse
the projection pattern of iRGCs is not feasible because the
lack of Zic2 in the retina causes the elimination of the
ipsilateral projection (Herrera et al, 2003). Taking advantage
of our previous observation that ectopic expression of Zic2 in
the central retina induces the expression of Sert (Figure 3B),
we took a gain-of-function approach instead. Plasmids bear-
ing EGFP, as a control, or Zic2 plus EGFP (Zic2/EGFP)-coding
sequences were expressed ectopically in RGCs from the
centre of the retina by in utero electroporation at E13.5. We
analysed the projection pattern of these targeted axons in
both the dLGN and SC in P15 mice when the axonal reﬁne-
ment/segregation process is complete (Figure 5). In order to
label the endogenous ipsilateral and contralateral projections
at the visual targets, electroporated mice were monocularly
injected with an axonal tracer (Cholera toxin subunit B
(CTB)-Alexa-Fluor 594).
Axons expressing EGFP alone were found projecting inside
the territory occupied normally by contralateral axons in both
dLGN and SC (Figure 5). As reported previously, ectopic
expression of Zic2/EGFP in the centre of the retina caused
B40–45% of targeted RGCs to switch laterality and project
ipsilaterally (Garcia-Frigola et al, 2008; Petros et al, 2009).
The analysis of these ectopic Zic2-positive axons revealed that
they were able to ﬁnd their way to the ipsilateral dLGN and SC
in spite of being in the wrong hemisphere. Furthermore,
although their axonal arborization was deﬁcient and neurite
processes were poorly elaborated, they were all found in the
territory normally occupied by contralateral axons (Figure 5).
This demonstrates that, although their laterality at the chiasm
is altered, central RGCs expressing ectopically Zic2 still project
into the contralateral eye-speciﬁc domain as it corresponds to
their ‘central-contralateral’ position in the retina.
RGCs that ectopically express Zic2 do not reﬁne
properly in the SC
Although RGCs expressing Zic2 ectopically projected
into contralateral domains, their projection phenotype was
Figure 5 Axons that ectopically express Zic2 project into the contralateral-speciﬁc domain in the visual targets. (A) Summary of the
experimental approach used to visualize retinal axons at the dLGN and SC. Plasmids bearing EGFP or Zic2/EGFP were introduced in central
RGCs by in utero electroporation at E13.5. At P14, electroporated mice were monocularly injected with the axonal tracer cholera toxin subunit
B (CTB-Alexa594) and they were killed 1 day later. Dashed lines indicate the level of the sections. Representative coronal sections through the
dLGN of P15 mice electroporated with EGFP (B) or with Zic2/EGFP (C, D) show that all targeted axons project into contralateral-speciﬁc
domains. (E–G) Representative coronal sections through the SC of P15 mice electroporated with EGFP or with Zic2/EGFP show that all targeted
axons project into contralateral-speciﬁc domains. Red-dashed lines outline the territory occupied by axons coming from the CTB-injected eye.
White-dashed lines outline the territory occupied by axons coming from the non-injected eye. m, medial; l, lateral. Scale bars: 100mm.
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in the serotonin pathway produces more evident phenotypes
in the SC than in the dLGN, we studied the projection of
targeted axons in the SC of electroporated animals. We ﬁrst
characterized the projection pattern of central RGCs during
development. Brains of mice electroporated at E13.5 with
EGFP alone were killed at three different time points, P0, P4
and P15, dissected out and sectioned sagitally to evaluate the
rostrocaudal distribution of the targeted projections. At P0
and P4, EGFP-positive axons had reached the most caudal
area of the colliculus. By P15, targeted axons had already
reﬁned and formed complex and elaborated arbors in the
medial area of the colliculus contralateral to the electropo-
rated eye (Figure 6). EGFP-positive axons were not found in
the ipsilateral SC.
Next, we analysed the projections of Zic2/EGFP-electro-
porated axons. In this case, targeted axons were always found
in both the contralateral and the ipsilateral side of the
Figure 6 Axons that ectopically express Zic2 do not reﬁne properly at the colliculus. (A–G) Pictures show representative sagittal sections of the
SC from P0, P4 and P15 mice that were electroporated with plasmids bearing the coding sequence of EGFP in the central retina at E13.5. (A)I n
the hemisphere contralateral to the electroporated eye, EGFP-positive axons coming from the central retina reach the caudal region of the
colliculus at P0. (C) Four days later, at P4, although a high proportion of axons were found in the caudal collicular region, many of them have
started to reﬁne and arborize into more central areas. (F) By P15, all axons have already reﬁned and they can be found only in central areas of
the SC. (B, D, G) Pictures show that EGFP-positive axons were not found in the ipsilateral side at any stage. (I–P) Pictures show representative
sagittal sections of the SC from P0, P4 and P15 mice that were co-electroporated in the central retina at E13.5 with plasmids bearing the coding
sequence of Zic2 and EGFP. (I, K) In the hemisphere contralateral to the electroporated eye, Zic2/EGFP-positive axons coming from the central
retina reach the caudal region of the colliculus at P0 and P4. (O) By P15, many axons have already reﬁned and they can be found in central
areas of the SC. In this case, in contrast to the EGFP control, some targeted axons were detected in the caudal areas. (J, M, P) In the ipsilateral
side of Zic2/EGFP-electroporated mice, targeted axons were found in the caudal colliculus at all the stages, including P15. Red arrowheads
highlight the most caudal position where targeted axons were visualized. (E, N) Schematic representations of the projection phenotypes along
the visual pathway summarize the results obtained in mice electroporated at E13.5 and analysed at P0 and P4. (H, Q) Schematic representation
of the projection phenotype in the SC of animals electroporated with EGFP or Zic2/EGFP at E13.5 and analysed at P15. (R) Quantitative
comparison of ﬂuorescence measurements in the contralateral colliculus of P15 mice electroporated with EGFP or with Zic2/EGFP at E13.5.
Despite no overall signiﬁcant differences were found comparing the axonal distribution in the sections of EGFP and Zic2/EGFP-electroporated
mice, it is important to note the increase in the ﬂuorescence values of the Zic2/EGFP in the most caudal point of the SC. (S, T) High
magniﬁcation pictures of the caudal-squared areas in (F) and (O). The red-dashed lines delineate the caudal limit of the correct TZ according to
the central location of the targeted RGCs in the retina. (U) Quantiﬁcation of the levels of ﬂuorescence in the caudal region of collicular sagittal
sections (yellow circle) from P15 mice shows a signiﬁcant increase in the amount of ﬂuorescence in Zic2/EGFP-electroporated mice compared
with the controls. Data obtained from six animals and three sections from each animal for each condition (*Pp0.05, Student’s unpaired t-test).
(V) Quantitative analysis of ﬂuorescence measurements in sagittal sections comparing contralateral versus ipsilateral P15 colliculus
electroporated with Zic2/EGFP show that the distribution of the projections on each side is signiﬁcantly different. Error bars indicate
±s.e.m. Statistical analysis was performed using a two-way ANOVA (F(5.144) position projection type¼20.247, Pp0.0001). Data obtained from four
animals and three sections from each animal for each condition. r, rostral; c, caudal. Scale bars: 100mm.
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caudal areas of the SC, similar to when only EGFP is electro-
porated. However, at P15, defects were seen in EGFP/Zic2-
positive axons in both the ipsilateral and contralateral SC. In
the ipsilateral SC, EGFP/Zic2 axons remained in caudal areas
instead of in the central region appropriate to the location of
their cell bodies in the retina. In addition, the terminal ﬁelds
of these neurons were diffuse, showing a deﬁcient elabora-
tion of axon arbors (Figure 6). In the contralateral SC, most
EGFP/Zic2-electroporated axons projected properly into their
correct termination zone in the medial SC. However, we
found consistently that a small proportion were located
ectopically in caudal areas (Figure 6R). As we co-electropo-
rated two plasmids (pCAG-Zic2 and pCAG-EGFP), it is likely
that axons correctly projecting and arborizing in the medial
areas of the colliculus are those that express EGFP but do not
co-express Zic2 or express it at low levels. Conversely, the
axons that misproject into caudal areas are likely Zic2-posi-
tive ﬁbres that had already passed the midline when ectopic
Zic2 expression was initiated. In order to quantify the extent
of this abnormal projection in the contralateral SC, we
performed ﬂuorescence quantiﬁcations on the caudal colli-
cular area of animals electroporated with Zic2/EGFP and
found a signiﬁcant increase in ﬂuorescence in this area
compared with controls electroporated only with EGFP
(Figure 6S–U). This projection of Zic2-transfected axons
beyond their topographically correct TZ resembles the pro-
jection errors caused by pharmacological or genetic alteration
of serotonin levels during development (Bastos et al, 1999;
Upton et al, 2002; Ravary et al, 2003; Gonzalez et al, 2008).
Zic2-positive but not Zic2-negative RGC axons
respond to pharmacological blockage of Sert
Next, we investigated whether the lack-of-reﬁnement pheno-
type observed in the axons ectopically expressing Zic2 is due
to the misexpression of Sert. In order to test this hypothesis,
we electroporated E13.5 embryos in the central retina and
waited until the mice were born. Then, we administered a
daily dose of ﬂuoxetine, a well-known inhibitor of Sert (Wong
et al, 1974, 1995), until they were analysed at P15. Fluoxetine
treatment induced a signiﬁcant change in the TZs of RGC
axons electroporated with Zic2, producing a medial shift of
the projections back to their topographically correct location
(Figure 7A–C). In general, we also observed that after ﬂuox-
etine treatment, Zic2-positive ﬁbres showed a more exuber-
ant elaboration of axon arbors compared with Zic2-positive
saline-treated ﬁbres.
In the contralateral SC of P15 mice electroporated with
Zic2/EGFP, we focused our analysis in the caudal collicular
areas (Figure 7D and E) that contain the axons with a defect
in reﬁnement. We found that in ﬂuoxetine-treated mice,
the extent of aberrant axon projections within the caudal
collicular area was reduced signiﬁcantly compared with
saline-treated animals (Figure 7D–F). We cannot rule out
the possibility that Zic2 controls other molecules that also
participate in reﬁnement processes at the SC. Nevertheless,
the partial rescue of the Zic2 missexpression phenotype by
blocking Sert demonstrates clearly that Zic2 upregulates Sert,
which then inhibits the proper reﬁnement and arborization of
retinal axons at the colliculus.
Previous reports have examined how alterations in seroto-
nin levels affect the reﬁnement of ipsilateral RGCs axons at
the SC (Bastos et al, 1999; Upton et al, 2002; Gonzalez et al,
2008). However, the phenotype of contralateral RGC axons
after changing serotonin concentrations has not been evalu-
ated, likely because the analysis of contralateral axons is
technically more challenging. To investigate this issue, we
electroporated EGFP in central RGCs at E13.5 followed by
treatment with ﬂuoxetine or saline as described above. EGFP-
targeted axons project to their correct TZ, the medial portion
of the colliculus and the degree of arborization was very
similar in ﬂuoxetine and saline-treated animals (Figure 7G–I).
This demonstrates that inhibition of Sert does not affect
the reﬁnement of cRGCs. Together with previous results,
these ﬁndings demonstrate that Zic2 controls speciﬁcally
the reﬁnement of ipsilateral but not contralateral axons in
the primary visual targets by controlling directly the expres-
sion of Sert.
Zic2 modulates reﬁnement at the SC independently
of controlling laterality at the midline
As the stronger reﬁnement phenotype in Zic2-electroporated
animals was found in the ipsilateral SCs, we wanted to rule
out the possibility that switching laterality at the midline
affects axonal reﬁnement at the targets. To address this, we
expressed ectopically EphB1 in the central region of the retina
and analysed postnatally the retinocollicular projections.
In agreement with previous reports, we found that ectopic
expression of EphB1 resulted in 15–20% of the targeted axons
projecting ipsilaterally (Garcia-Frigola et al, 2008; Petros et al,
2009). However, we found that EphB1-electroporated axons
on both the ipsilateral and contralateral SC formed TZs in the
topographically correct location (Figure 8A). This demon-
strates that a switch in axonal laterality does not determine
the eye-speciﬁc territory, topographic projection pattern or
reﬁnement at the target. This result also suggests that contact
of RGCs axons with midline cues does not generate a retro-
grade signal that modulates the projection patterns at the
targets. We also found that Sert expression is independent of
EphB1. In mice lacking EphB1, expression of Sert in the retina
was maintained in a pattern indistinguishable from wild type
(Figure 8B).
Next, we asked if Sert is required for guidance at the
midline. In contrast to ectopic expression of Zic2 or EphB1,
we found that electroporation of Sert (pCAG-Sert) in central
RGCs did not affect guidance at the midline (Figure 8D).
In agreement with previous reports (Upton et al, 2002), we
also found that Sert-deﬁcient mice did not exhibit any altera-
tion in the number of ipsilateral RGC axons (Supplementary
Figure S2). This indicates clearly that Sert does not have a
function in controlling guidance at the midline. Together,
these results demonstrate that axon guidance at the midline
and reﬁnement of ipsilateral axons in the SC are independent
phenomena. Zic2 has a function in both processes by activat-
ing independently different effectors: EphB1 to control later-
ality and Sert to modulate reﬁnement at the visual targets.
Discussion
In this study, we show that the transcription factor Zic2 has
an important function in controlling eye-speciﬁc reﬁnement
in the SC by inducing the expression of Sert speciﬁcally in
iRGCs. Together with previous results, this demonstrates that
Zic2 determines the ipsilateral phenotype in the retinofugal
Eye-speciﬁc reﬁnement controlled by Zic2
C Garcı ´a-Frigola and E Herrera
&2010 European Molecular Biology Organization The EMBO Journal VOL 29 | NO 18 | 2010 3177pathway by regulating the transcription of at least two
downstream effectors, EphB1 and Sert, which act sequen-
tially at different steps of the maturation process in the
visual pathway.
Zic2 controls the transient expression of Sert during
development
Several days after the generation of the raphe neurons,
serotonin accumulation can be detected in several classes
of thalamic, cortical, hypothalamic and retinal neurons.
These neurons do not express tryptophan hydroxylase
(Tph) or dopa decarboxylase (Aadc), which are required for
serotonin synthesis, or the catabolic enzymes monoamine
oxidase A and B. The presence of serotonin in these neurons
is explained by the transient expression of Sert that reuptakes
serotonin from the extracellular space (Gaspar et al, 2003).
The transcriptional network controlling the levels of seroto-
nin in the raphe nuclei has been intensely studied. The
transcription factor Pet1 is expressed in serotonergic neurons
and directly activates the transcription of genes that are
involved in the synthesis (Tph and Aadc) and uptake (Sert)
of serotonin. However, not much is known about the regula-
tion of the transient Sert expression in non-aminergic neu-
rons. The transcriptional mechanisms controlling serotonin
Figure 7 Zic2-positive but not Zic2-negative axons respond to ﬂuoxetine treatment. The pictures show representative sagittal sections of the
SC from P15 mice that were electroporated at E13.5 in central retina and then treated with saline or ﬂuoxetine from P0 to P15. To summarize
the results, schematic representations of collicular sections are shown below each image. The red-dashed lines delineate the caudal limit of the
correct TZ according to the central location of the targeted RGCs in the retina. (A, B) In the ipsilateral SC of animals electroporated with Zic2/
EGFP, axons projected to more rostral areas in ﬂuoxetine-treated than in saline-treated animals. (C) Quantitative analysis of ﬂuorescence
measurements in sagittal sections of colliculus electroporated with Zic2/EGFP treated with saline versus ﬂuoxetine shows a signiﬁcant
displacement of the projection to more rostral positions after ﬂuoxetine treatment (F (5.240) position treatment¼2.86, P¼0.016). Data obtained
from ﬁve animals and four equivalent sections from each animal for each condition. (D, E) High-magniﬁcation pictures of the caudal portion of
the contralateral SC (squared area) of mice electroporated with Zic2/EGFP show that axons treated with ﬂuoxetine project to more rostral areas
than those treated with saline. (F) Quantiﬁcation of the levels of ﬂuorescence in the caudal region of collicular sagittal sections (yellow circle)
shows a signiﬁcant decrease in the amount of ﬂuorescence in the ﬂuoxetine-treated animals compared with the saline-treated animals
(*Pp0.001, Student’s unpaired t-test). Data were obtained from six animals and three sections from each animal for each condition. (G, H)I n
the contralateral SC of animals electroporated with EGFP, axons project in the medial region in both saline and ﬂuoxetine-treated mice.
As EGFP axons did not project into the ipsilateral side, the ipsilateral colliculi are not shown. (I) No signiﬁcant differences were found after
quantitative analysis of ﬂuorescence measurements in sections of SCs from EGFP-electroporated mice treated with saline versus ﬂuoxetine.
Data were obtained from three animals and three equivalent sections from each animal per treatment. Error bars indicate±s.e.m. Statistical
analysis was performed using a two-way ANOVA. r, rostral; c, caudal. Scale bars: 100mm.
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covered in the raphe nuclei, as none of the genes that regulate
the serotonin phenotype in the raphe have been found in
areas that transiently express Sert. The results presented here
support this hypothesis and point to Zic2 as the ﬁrst tran-
scription factor that regulates Sert expression and serotonin
homeostasis in non-aminergic neurons during development.
Sert as a modulator of activity-dependent reﬁnement
We demonstrate here that Zic2 induces directly the transcrip-
tion of Sert in iRGCs. Sert is known to adjust the extracellular
concentration of serotonin (Wong et al, 1974; Jennings et al,
2006). Serotonin signalling has a critical function in axonal
reﬁnement processes in several systems and animal models.
Genetically modiﬁed mice lacking monoamine oxidase A, an
enzyme that breaks down serotonin, exhibit severe disrup-
tions in the barrels domains of the primary somatosensory
cortex (Rebsam et al, 2002) as well as in eye-speciﬁc segrega-
tion in the dLGN and SC (Upton et al, 1999). In rodents,
increased levels of serotonin prevent the segregation of
retinocollicular axon terminals (Upton et al, 2002) and de-
creasing serotonin levels by parachlorphenyalanine treatment
or by neonatal tryptophan restriction in the diet, also affect
retinofugal ﬁbre reﬁnement (Upton et al, 1999; Gonzalez
et al, 2008). Similarly, pharmacological blockade or genetic
removal of Sert perturbs eye-speciﬁc reﬁnement of retinal
axons at the visual targets (Bastos et al, 1999) or barrels
formation in the cortex (Xu et al, 2004).
As cAMP signalling is essential for the segregation of eye-
speciﬁc inputs (Stellwagen et al, 1999; Pham et al,2 0 0 1 ;
Ravary et al, 2003) it is likely that, as in other systems,
serotonin signalling acts in the visual system by affecting
cAMP levels. Serotonin receptors (5HT1B) are localized in all
RGCs axon terminals (Salichon et al, 2001). The 5HT1B
receptor is negatively coupled to the adenylate cyclase 1
(AC1) through G-proteins of the Gai subtype (Lin et al,
2002). AC1 has an important function in the reﬁnement of
the ipsilateral retinal projection in both the LGN and the SC,
acting presynaptically in RGCs to modulate the reshaping of
axon terminal arbors in the retinofugal projections and not
affecting axon guidance in the travelling of retinal ﬁbres to
the targets (Ravary et al, 2003; Plas et al, 2004; Nicol et al,
2006, 2007). In cRGCs, the activation of the 5HT1B receptor
would inhibit cAMP production in the axon terminals.
However, retinal axons that express adequate levels of
Sert can internalize extracellular serotonin and relieve
5HT1B-mediated inhibition, allowing the production of
cAMP and promoting the reﬁnement process (Supple-
mentary Figure S3). Supporting this theory, mice lacking
another component of the machinery, the 5HT1B receptor,
also show defects in eye-speciﬁc segregation in the LGN and
SC (Upton et al, 1999).
Figure 8 Zic2 controls reﬁnement at the SC independently of controlling axon guidance at the midline. (A) Pictures show representative
sections of the SC from P15 mice electroporated at E13.5 with CAG-EphB1 plasmids. Axons ectopically expressing EphB1/EGFP project to the
medial region in both, the contralateral and the ipsilateral SC. Schematic representations of collicular sections are shown below each image.
Dashed lines delineate the caudal limit of the correct TZ according to the location of targeted RGCs in the retina. In the right panel, the
projection phenotypes are summarized. Sections from four different embryos electroporated with EphB1/EGFP were analysed and all of them
showed similar phenotypes at the colliculus. r, rostral; c, caudal; (B) Coronal section from an E16.5 EphB1
 /  VT retina, in which an
immunostaining against Zic2 (green) was combined with in situ hybridization to Sert (red) shows that expression of Sert is normal in the
absence of EphB1. np, neural progenitors; cb, ciliary body. Scale bars: 100mm. (C) Immunostaining against Sert (red) in sections from E16.5
embryos electroporated with Sert/EGFP (green) at E13.5 conﬁrms ectopic expression of Sert in the targeted area. (D) The picture shows
the optic chiasm region of E16.5 embryos electroporated with different plasmids at E13.5. In embryos electroporated with EGFP alone or with
Sert/EGFP, all targeted axons cross the midline, contrasting with Zic2/EGFP or EphB1/EGFP-electroporated embryos that show ipsilateral and
contralateral axons at the optic chiasm. Red arrows point to the ectopic ipsilateral projection. Red-dashed lines mark the midline. on, optic
nerve; iot, ipsilateral optic tract; cot, contralateral optic tract. Scale bar: 500mm.
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increasing or decreasing the levels of extracellular serotonin
affect axon reﬁnement in several sensory systems (Upton
et al, 1999, 2002; Xu et al, 2004; Rebsam et al, 2005; Gonzalez
et al, 2008). Sert null mice that have accumulated serotonin
extracellularly show a ‘lack-of-reﬁnement’ phenotype and
mice that ectopically express Sert (induced by Zic2) exhibit
similar alterations in the reﬁnement process. Interestingly, it
has been reported that rather than absolute cAMP levels,
the appropriate balance of cAMP production and degradation
is essential for retinal axon reﬁnement (Nicol et al, 2007). It is
thereby likely that alterations, positive or negative, in the
levels of serotonin disturb the production of cAMP oscilla-
tions preventing axonal reﬁnement of ipsilateral axons.
Eye-speciﬁc layering at the targets: dependent
or independent of laterality at the midline?
A number of observations indicate that axon laterality at the
midline and the establishment of projection patterns and eye-
speciﬁc segregation at the visual targets are independent
events. The Robo and Comm mutants in Drosophila
(Karlstrom et al, 1996), the astray mutants in zebraﬁsh
(Wolf and Chiba, 2000), the Siamese and albino cats
(Guillery, 1969; Creel et al, 1982; Kliot and Shatz, 1985),
and the achiasmatic sheepdogs (Williams et al, 1994) show
normal projection patterns at the ﬁnal targets despite the
fact that they all have alterations in the ipsi/contra ratio. In
agreement with these observations, when we ectopically
expressed EphB1 to force some cRGCs axons to switch
laterality at the midline, they projected correctly in the
topographic collicular area corresponding to their retinotopic
position, a phenomenon similar to the situation previously
described for the dLGN (Rebsam et al, 2009). Our data
conﬁrm that divergence at the midline and determination of
the projection phenotype at the targets are independent
events. However, our ﬁndings also demonstrate that these
processes are not unrelated because both require the action of
a common transcription factor, Zic2.
In addition, in EphB1 null mice around 60% of the axons
from the VTretina change laterality and are misrouted to the
contralateral LGN (Williams et al, 2003). Despite the change
in laterality, these misrouted axons target in the topographic
area that corresponds to the ipsilateral domain but in
the contralateral side and segregate perfectly from the real
contralateral axons, forming a patch that never mingle with
the endogenous contralateral projections (Rebsam et al,
2009). We have observed that the levels of Sert in the VT
region of EphB1
 /  mice are normal, which indicates that
these misrouted axons still express endogenous levels of Sert
and argues for a function of this transporter in the segregation
of VTaxons even when they project in the wrong hemisphere.
Zic2, the ﬁrst transcription factor involved in the
establishment of RGC axonal reﬁnement
We have shown that ectopic expression of Zic2 in central
retina induces axons to project to mediocaudal areas of the
SC. We have excluded the possibility that this phenotype is
caused by a change in laterality. An alternative explanation to
this ﬁnding is that Zic2 regulates some additional molecules
involved in targeting at the colliculus. However, this is
unlikely because ipsilateral axons, which naturally express
Zic2, do not project caudally but rostrally. It seems more
plausible that ectopic expression of Zic2 in central retina
affects the reﬁnement process of these neurons because the
relative levels of serotonin they sense are not perfectly
balanced. Axons from the central retina ﬁrst overshoot their
TZs to innervate caudal positions of the SC to then retract and
project in central positions (Simon and O’Leary, 1992). The
ectopic expression of Zic2 in cRGCs leads to a lack-of-reﬁne-
ment phenotype of their axons, a defect that is partially
reverted after application of ﬂuoxetine indicating, at least in
part, this phenotype is caused by induction of Sert.
It is not clear whether reﬁnement and segregation are
independent processes but changes in serotonin levels affect
both. The cRGCs that are neighbouring the iRGCs arise from
the VT retina and project to similar areas than ipsilateral
ﬁbres on the contralateral side but they eventually segregate
from them. On the basis of this premise, and assuming that
levels of EphA/ephrinAs and other axon guidance molecules
determine the ﬁnal projection pattern of all retinal axons,
it is possible that iRGCs only differentiate from cRGCs in two
aspects: (1) the decision of avoiding the midline and (2) the
expression of molecules that permit the reﬁnement/segrega-
tion process. Our results are on line with this idea because
ectopic expression of Zic2 does not cause a change in the
identity of central-contralateral cells to now project into
the ipsilateral domain. According to this view, Zic2 would
be a ‘master-gene’ that provides the necessary molecules
to distinguish iRGCs from cRGC in these two stages of
differentiation.
Overall, the results presented here link, for the ﬁrst time,
early molecular events in axon guidance with late activity-
dependent reﬁnement processes and points to Zic2 as an
important regulator of different steps during the establish-
ment of the visual circuitry in mammals.
Materials and methods
Animals
Mice from BDF1 (DBA2 x C57/B6) WT, Zic2
þ/kd (Nagai et al, 2000),
EphB1
 /  (Williams et al, 2003) and Sert
 /  (Bengel et al, 1998)
strains were kept in a timed pregnancy breeding colony at the
Instituto de Neurociencias (IN). Animal protocols were approved by
the IN Animal Care and Use Committee.
Microarrays analyses
Total RNA was extracted from triplicate pools of 14–16 retinal
VTsegments from E16.5. WTand Zic2
kd/kd embryos. Samples were
then processed as in Lopez de Armentia et al (2007). The list of
signiﬁcantly changed probe sets shown in Figure 1 was obtained
after ﬁltering by signal intensities (20–100th percentile in the raw
data), statistical signiﬁcance (Po0.05, unpaired t-test) and fold
change (42.0) using GeneSpring GX software (Agilent Techno-
logies, Santa Clara, CA).
In situ hybridization and immunohistochemistry
In situ hybridization was performed as in Schaeren-Wiemers and
Gerﬁn-Moser (1993). To perform ﬂuorescent reactions, TSA system
(Perkin Elmer) was used following the manufacturer’s instructions.
To generate Sert probes, the following primers were used:
ATCGTGGTCATCACTTGCATC-, GTTACACAGCATTCATGCGG-. Immu-
nohistochemistry protocols were performed as in Herrera et al
(2003) and Garcı ´a-Frigola et al (2008). Anti-Zic2 (Brown et al, 2003)
and anti-SERTantibodies (Blakely et al, 1994) were used at 1:10000
and 1:1000, respectively.
Quantitative RT–PCR
Retinas of E13.5 WT embryos were electroporated in utero with
CAG-EGFP or CAG-Zic2 plasmids and qRT–PCR was performed as
in Garcı ´a-Frigola et al (2008).
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A fragment of 130bp was cloned into pGL3-Basic (Promega) (pGL3-
Sert prom). Mutations in the CRE-like, GC-rich and Gli-BSs were
introduced by site-directed mutagenesis giving rise to the following
sequence substitutions: GGCGGCG into GAATTCG; TGACGCA into
GGATCCA and GGGGCCG into GAATTCG. Luciferase reporter
plasmids carrying the corresponding mutations were named:
pGL3-Gli mut, pGL3-CRE-like mut and pGL3-GC mut. The pCAG-
Zic2 or the empty pCAG were co-expressed with the luciferase
reporter plasmids. 293HEK cells plated in 24-well plates were co-
transfected with 0.4mg of a luciferase reporter plasmid (pGL3-Basic,
pGL3-Sert prom, pGL3-Gli mut, pGL3-CRE-like mut or pGL3-GC
mut), 10ng of SV40-bgal and 0.4mg of pCAG or pCAG-Zic2. After
24h, cells were lysated and luciferase and b-galactosidase activities
measured using Luciferase Reporter and Beta-Glo Assay Systems
(Promega) following the manufacturer’s guidelines. Each sample
was assayed in triplicate and luciferase activities were normalized
using b-galactosidase. The fold increase in luciferase activity was
calculated as a ratio between the activity in the presence of Zic2 and
the activity measured in the presence of the empty vector pCAG for
each construct. Data were statistically analysed with SPSS using
Student’s unpaired t-test.
Chip assays
VTretinal quadrants from 2litters of E16.5 embryos were dissected
out and proteins cross-linked to DNA in a 1% formaldehyde
solution for 20min at room temperature. ChIP was carried out as
described in the Upstate Biotechnology protocol. Zic2 was
immunoprecipitated using anti-Zic2 antibodies (Brown et al,
2003) and control immunoprecipitations were performed using
anti-acetylated-Histone3 (Sanchis-Segura et al, 2009), rabbit IgGs or
no antibody. Primers used for ampliﬁcation: Sert promoter: -CTGC
TGTATGTGCAGGAATG-, -CGCGCTATTTGTACTTGCGG-, Control
-GCTGGTAGTTTGTCAGTGCCC-, AGGTCCTGCTCCGTGTCACTCC-.
In utero electroporation, ﬂuoxetine treatment and CTB
injections
Electroporation experiments were carried out in BDF1
(DBA2 C57/B6) mice. Retinal in utero electroporation was
performed as described in Garcia-Frigola et al (2007). For postnatal
analysis in the LGN and SC, electroporated pups were killed and
ﬁxed at P15. Brains were sectioned for analysis and quantiﬁcation
of retinal projections in the targets. For ﬂuoxetine treatment, a daily
injection of ﬂuoxetine (10mg/kg, Sigma) or saline was adminis-
tered subcutaneously from P1 to P4, and then intraperitoneally
from P5 to P15. The corresponding retinas were removed and ﬂat
mounted to conﬁrm electroporation in the central retina and to
obtain a retinal electroporation ratio (retinal-electroporated area/
total retinal area). CTB injections were performed at P14 as in
Rebsam et al (2009).
Analysis and quantiﬁcation of axonal projections in the SC
Brains of mice whose retina was electroporated around the optic
disc and the ratios of electroporation were comparable were used to
quantify possible differences in the retinocollicular projections
along the rostrocaudal axis of the SC.‘Comparable’ was deﬁned as
having a retinal electroporation ratio o12% different. Sections of
the SC of equivalent lateromedial levels were analysed. For each
section, the rostrocaudal length of the SC was divided into six
portions and ﬂuorescence intensity in a circular area of constant
size inside of each portion in contact with the collicular surface
was measured using Image J. In the cases where only the caudal
portion of the SC was analysed at higher magniﬁcation, only one
measurement was made. For each value, background ﬂuorescence
values were subtracted from absolute values. Then, value of
absolute ﬂuorescence was divided by the value of average
ﬂuorescence in the section, generating values of relative ﬂuore-
scence. Data were statistically analysed with SPSS using a two-way
ANOVA to evaluate the interactions between side of the colliculus
(ipsi–contra) and the position of the projection or pharmacological
treatment and position of the projection. All images were taken
using DC500 camera (Leica) coupled to a Leica DM 5000B
microscope. For quantiﬁcation of the projections at the SC, pictures
were taken with the  5 objective except for the high magniﬁcation
images that were taken using  10 objective.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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